Continue to invest in and foster national and international collaborations to deliver the best research output.
During the years 2009/10-2013/14, our strategy is to:
Consider current and potential interactions with the pharmaceutical and biotechnology industries and develop relationships as appropriate.- Continue to invest in all collaborations that help us work towards our Goals.
- Investigate the possibility of leading an Innovative Medicines Initiative bid potentially in biomarkers.
- Examine the potential for broader Charity-level international partnerships.
